Biology Atlas

Map / The cascade

step · intermediate · partly written

GWAS and variant prioritisation

One step of the screening cascade walk-through, from disease to clinic.

What is done

Two different activities. A GWAS compares many people to flag regions of the genome associated with a trait (P below 5 x 10^-8); variant prioritisation filters and classifies one patient's variants. They meet only at the next step, where a region or a variant is tied to a gene. 12

Reported, not yet replicated

Costs

The whole-genome sequencing cost already filed in the atlas is 221 USD per 30x genome at one core facility (undated page; excludes analysis and storage). No GWAS cost was found in an opened source. 3

Reported, not yet replicated

Proves

That a region is statistically associated with a trait in the population studied, or, for one patient, that a variant meets the evidence rules for a class. 12

Reported, not yet replicated

Cannot prove

Which variant is causal, which gene it acts on, and which direction a drug should push. Over 80% of associations lie outside coding regions, and the first clear success was intronic. 45

Reported, not yet replicated

Assays

ML role

Models rank variants and genes after the association: the locus-to-gene model reached precision 0.73 and recall 0.53 at score 0.5 against 0.56 and 0.60 for the nearest gene, with 43.2% of loci receiving no gene. 6

Reported, not yet replicated

Reports

Scenarios

Still open here

Not yet written: Regulators require, Modality notes.

Linked from

Sources

  1. Risch, N., Merikangas, K.. The Future of Genetic Studies of Complex Human Diseases. Science (1996). paper; opened 2026-11-17 all records citing this
  2. Richards, S., Aziz, N., Bale, S., et al.. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine (2015). paper; opened 2026-11-17 all records citing this
  3. University of Minnesota Genomics Center: human whole-genome sequencing. University of Minnesota (2026). organisation-page, not peer reviewed; opened 2026-11-17 all records citing this
  4. Manolio TA, Collins FS, Cox NJ, et al.. Finding the missing heritability of complex diseases. Nature (2009). paper; opened 2026-11-17 all records citing this
  5. Klein, R., Zeiss, C., Chew, E., et al.. Complement Factor H Polymorphism in Age-Related Macular Degeneration. Science (2005). paper; opened 2026-11-17 all records citing this
  6. Mountjoy E, Schmidt EM, Carmona M, et al.. An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci. Nat Genet (2021). paper; opened 2026-11-17 all records citing this
History of this record (5)

This record has been changed 5 times, on the dates below. The note kept against each change is written for the people who maintain the atlas, in their own shorthand, so it is not shown here; it is in the record itself.

Order
2
Stage
target-id
Status
partly written
Last updated
2026-11-17
Record
content/cascade/gwas-and-variant-prioritisation.json